UK based biotech start-up Kuano raises US$1.38M to venture into Artificial Intelligence-driven drug discovery

UK – Kuano, a UK-based startup that deals in Artificial Intelligence, has raised £1M in seed funding to further expedite the development of its platform for the discovery of therapeutics meant to target enzyme inhibition. The £1 million in funding will go towards expanding the technology team and the further development of the company’s platform and assets, including its own range of novel therapeutics. It will also be used to create a data bank for use in its work with academic and commercial partners. Kuano’s software platform creates rapid, cost…

Read More